Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors

Clinical trial NCT04640480 · COMPLETED

Trial details

NCT number: NCT04640480
Sponsor: SN BioScience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Breast Cancer Pancreas Cancer Ovarian Cancer Small-cell Lung Cancer Gastric Cancer Head and Neck Cancer

Start date: 2020-10-21
Primary completion: 2026-01-05
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.